Report Feature
The future of the global applied immunology market looks promising with opportunities in the rheumatoid arthritis, psoriatic arthritis, plaque arthritis, ankylosing spondylitis, inflammatory bowel disease, and prophylaxis of organ rejection. The global applied immunology market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are rising awareness regarding immuological diseases, increasing incidence of immunological and autoimmune diseases due to environmntal factors.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global applied immunology market report, please download the report brochure.
In this market, immunosuppressant is the fastest growing drug class segment of applied immunology. Growth in various segments of the applied immunology market are given below:
The study includes trends and forecast for the global applied immunology market by drug class, disease indication, distribution channel, and region as follows:
By Drug Class [Value ($ Million) shipment analysis for 2014 – 2025]:
- Monoclonal Antibody (mAb)
- Fusion Proteins
- Immunosuppressants
- Polyclonal Antibody (pAb)
- Others
By Disease Indication [Value ($ Million) shipment analysis for 2014 – 2025]:
- Rheumatoid Arthritis
- Psoriatic Arthritis
- Plaque Arthritis
- Ankylosing Spondylitis
- Inflammatory Bowel Disease
- Prophylaxis of Organ Rejection
- Others
By Distribution Channel [Value ($ Million) shipment analysis for 2014 – 2025]:
- Online
- Offline
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Spain
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Some of the applied immunology companies profiled in this report include AbbVie, Janssen Global Services (Johnson & Johnson), F. Hoffmann-La Roche, Amgen, Pfizer, Novartis, Astellas, Bristol-Myers Squibb Company, Merck Sharp & Dohme, UCB SA, and ALLERGAN.
Lucintel forecasts that theimmunosuppressants will remain the fastest-growing segment over the forecast period as it has higher achievements in efficient treatment leading to improved patient outcomes.
North America will remain the largest region over the forecast period due to increasing autoimmune and immunological diseases and adoption of advanced immunology drugs in the region.
|
Features of the Global Applied Immunology Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global applied immunology market by drug class (monoclonal antibody (mab), fusion proteins, immunosuppressants, polyclonal antibody (pab), and others), disease indication (rheumatoid arthritis, psoriatic arthritis, plaque arthritis, ankylosing spondylitis, inflammatory bowel disease, prophylaxis of organ rejection, and others), distribution channel (online and offline), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global applied immunology market? Q.5 What are the business risks and threats to the global applied immunology market? Q.6 What are the emerging trends in this applied immunology market and the reasons behind them? Q.7 What are some changing demands of customers in this applied immunology market? Q.8 What are the new developments in this applied immunology market? Which companies are leading these developments? Q.9 Who are the major players in this applied immunology market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this applied immunology market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global applied immunology market? |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Applied Immunology Market
4.1 Global Applied Immunology Market by Region
4.2.1 Market by Drug Class: Monoclonal Antibody (mAb), Fusion Proteins, Immunosuppressants, Polyclonal Antibody (pAb), and Others
4.2.2 Market by Disease Indication: Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Arthritis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, and Others
4.2.3 Market by Distribution Channel: Online and Offline
4.2.4 The United States Applied Immunology Market
4.2.5 The Canadian Applied Immunology Market
4.2.6 The Mexican Applied Immunology Market
4.3.1 Market by Drug Class: Monoclonal Antibody (mAb), Fusion Proteins, Immunosuppressants, Polyclonal Antibody (pAb), and Others
4.3.2 Market by Disease Indication: Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Arthritis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, and Others
4.3.3 Market by Distribution Channel: Online and Offline
4.3.4 The Applied Immunology Market of United Kingdom
4.3.5 The Spanish Applied Immunology Market
4.3.6 The German Applied Immunology Market
4.3.7 The French Applied Immunology Market
4.4.1 Market by Drug Class: Monoclonal Antibody (mAb), Fusion Proteins, Immunosuppressants, Polyclonal Antibody (pAb), and Others
4.4.2 Market by Disease Indication: Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Arthritis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, and Others
4.4.3 Market by Distribution Channel: Online and Offline
4.4.4 The Chinese Applied Immunology Market
4.4.5 The Indian Applied Immunology Market
4.4.6 Japanese Applied Immunology Market
4.5.1 Market by Drug Class: Monoclonal Antibody (mAb), Fusion Proteins, Immunosuppressants, Polyclonal Antibody (pAb), and Others
4.5.2 Market by Ingredients: Fish Meal, Fish Oil, Soybean Meal, Corn Meal, Vegetable Oil, Source of Carbohydrates and Binders, Additives, and Others
4.5.3 Market by Distribution Channel: Online and Offline
4.5.4 Brazilian Applied Immunology Market
7.1.1 Growth Opportunities for the Global Applied Immunology Market by Drug Class
7.1.2 Growth Opportunities for the Global Applied Immunology Market by Disease Indication
7.1.3 Growth Opportunities for the Global Applied Immunology Market by Distribution Channel
7.1.4 Growth Opportunities for the Global Applied Immunology Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
